PMID- 37957221 OWN - NLM STAT- MEDLINE DCOM- 20231115 LR - 20231124 IS - 2045-2322 (Electronic) IS - 2045-2322 (Linking) VI - 13 IP - 1 DP - 2023 Nov 13 TI - The role of MOTS-c-mediated antioxidant defense in aerobic exercise alleviating diabetic myocardial injury. PG - 19781 LID - 10.1038/s41598-023-47073-0 [doi] LID - 19781 AB - Myocardial remodeling and dysfunction are commonly observed in type 2 diabetes mellitus (T2DM). Aerobic exercise can partly alleviate diabetes-induced myocardial dysfunction through its antioxidant actions. MOTS-c is a potential exercise mimic. This study aimed to investigate the effects of MOTS-c on improving diabetic heart function and its mechanism and to identify whether MOTS-c improved antioxidant defenses due to aerobic exercise. Herein, we established a rat model of T2DM induced by high-fat diet combined with a low-dose streptozotocin injection. Interventions were performed using intraperitoneal injections of MOTS-c (i.p. 0.5 mg/kg/day, 7 days/week) or aerobic exercise training (treadmill, 20 m/min, 60 min/day, 5 days/week) for 8 weeks. Myocardial ultrastructure was assessed using transmission electron microscopy (TEM), myocardial lipid peroxidation levels (MDA), superoxide dismutase (SOD), glutathione (GSH), and catalase (CAT) levels were assessed using colorimetric methods, and molecular analyses including MOTS-c, Kelch-like ECH-associated protein 1 (Keap1), Nuclear factor E2-related factor 2 (Nrf2), adenosine 5'-monophosphate (AMP)-activated protein kinase (AMPK)and phospho-AMPK (p-AMPK) were examined using Western blot. The results showed that MOTS-c, with or without exercise, reduced myocardial ultrastructural damage and improved glucolipid metabolism and cardiac function in T2DM. Furthermore, MOTS-c increased antioxidant markers such as SOD, CAT, and the protein expression of myocardial MOTS-c, Keap1, Nrf2, and p-AMPK. MOTS-c with exercise treatment reduced myocardial MDA and increased p-AMPK significantly comparing to only exercise or MOTS-c alone. Our findings suggest that MOTS-c may be a helpful supplement for overcoming exercise insufficiency and improving myocardial structure and function in diabetes. CI - (c) 2023. The Author(s). FAU - Tang, Mi AU - Tang M AD - School of Physical Education, Xihua University, Chengdu, 610039, China. AD - Institute of Sports Medicine and Health, Chengdu Sport University, Chengdu, 610041, China. FAU - Su, Quansheng AU - Su Q AD - Institute of Sports Medicine and Health, Chengdu Sport University, Chengdu, 610041, China. FAU - Duan, Yimei AU - Duan Y AD - Institute of Sports Medicine and Health, Chengdu Sport University, Chengdu, 610041, China. FAU - Fu, Yu AU - Fu Y AD - Institute of Sports Medicine and Health, Chengdu Sport University, Chengdu, 610041, China. FAU - Liang, Min AU - Liang M AD - Institute of Sports Medicine and Health, Chengdu Sport University, Chengdu, 610041, China. FAU - Pan, Yanrong AU - Pan Y AD - Institute of Sports Medicine and Health, Chengdu Sport University, Chengdu, 610041, China. FAU - Yuan, Jinghan AU - Yuan J AD - Institute of Sports Medicine and Health, Chengdu Sport University, Chengdu, 610041, China. FAU - Wang, Manda AU - Wang M AD - Institute of Sports Medicine and Health, Chengdu Sport University, Chengdu, 610041, China. FAU - Pang, Xiaoli AU - Pang X AD - Institute of Sports Medicine and Health, Chengdu Sport University, Chengdu, 610041, China. FAU - Ma, Jiacheng AU - Ma J AD - Institute of Sports Medicine and Health, Chengdu Sport University, Chengdu, 610041, China. FAU - Laher, Ismail AU - Laher I AD - Department of Anesthesiology, Pharmacology and Therapeutics, Faculty of Medicine, University of British Columbia, Vancouver, BC, V6T 1Z3, Canada. FAU - Li, Shunchang AU - Li S AD - Institute of Sports Medicine and Health, Chengdu Sport University, Chengdu, 610041, China. lishunchang@cdsu.edu.cn. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20231113 PL - England TA - Sci Rep JT - Scientific reports JID - 101563288 RN - 0 (Antioxidants) RN - 0 (Kelch-Like ECH-Associated Protein 1) RN - EC 2.7.11.31 (AMP-Activated Protein Kinases) RN - 0 (NF-E2-Related Factor 2) RN - EC 1.15.1.1 (Superoxide Dismutase) SB - IM MH - Rats MH - Animals MH - *Antioxidants/metabolism MH - Kelch-Like ECH-Associated Protein 1/metabolism MH - *Diabetes Mellitus, Type 2/therapy/metabolism MH - AMP-Activated Protein Kinases/metabolism MH - NF-E2-Related Factor 2/metabolism MH - Exercise MH - Superoxide Dismutase/metabolism MH - Oxidative Stress PMC - PMC10643467 COIS- The authors declare no competing interests. EDAT- 2023/11/14 00:42 MHDA- 2023/11/15 06:42 PMCR- 2023/11/13 CRDT- 2023/11/13 23:28 PHST- 2023/05/24 00:00 [received] PHST- 2023/11/08 00:00 [accepted] PHST- 2023/11/15 06:42 [medline] PHST- 2023/11/14 00:42 [pubmed] PHST- 2023/11/13 23:28 [entrez] PHST- 2023/11/13 00:00 [pmc-release] AID - 10.1038/s41598-023-47073-0 [pii] AID - 47073 [pii] AID - 10.1038/s41598-023-47073-0 [doi] PST - epublish SO - Sci Rep. 2023 Nov 13;13(1):19781. doi: 10.1038/s41598-023-47073-0.